Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Veranex Design Control Guide

Veranex Design Control Guide

Veranex Design Control Guide

 

Effectively managing all design control requirements can be a smooth process, if planned and implemented in line with the product, business goals and regulations to avoid challenges for medical device manufacturers.

 

To assist you with this endeavor, our team has meticulously mapped out key steps of the Design Control process.

 

Please submit the form to access the guide:


Medical Device Vigilance: Important Considerations to Comply With the EU MDR

Vigilance reporting and postmarket surveillance of medical devices are among the many requirements documented in the EU MDR (2017/745) to ensure the...

Read More

Veranex Supports Philips Healthcare with Writing Manuscript of Medicare Claims Study of Mobile Cardiac Monitoring

By leading the manuscript development, Veranex supported Philips Healthcare in publishing real-world evidence data supporting the use of Mobile...

Read More

Veranex Presents Study Results at the National Kidney Foundation Spring Clinical Meeting

Dr. Manasi Datar and colleagues used conjoint analysis to estimate preferences regarding kidney disease testing from 401 PCPs via a web survey....

Read More